Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale
↑メーカーのみでなく、病院も詐欺に関係しているとのこと。
Among the law's provisions with direct application to physicians and teaching hospitals is its call for greater transparency and reporting of relationships between industry and providers. Specifically, the law requires U.S. manufacturers of drugs, medical devices, biologic agents, and medical supplies that are covered under Medicare, Medicaid, or the Children's Health Insurance Program to report to the government certain information related to payments and other transfers of value to physicians and teaching hospitals. This information will be made available on a public Web site. Morris told legislators, “The requirement of public disclosure of these payments will help the government, as well as the health care industry and the public, to monitor relationships and should have a sentinel effect to deter kickbacks and other inappropriate payment relationships.” Senator Charles Grassley of Iowa, a longtime Republican watchdog on physician–corporate relationships, had introduced similar “sunshine” provisions in separate legislation.
コメント
コメントはまだありません。
コメントを書く